Human induced pluripotent stem cells generated from epilepsy patients for use as in vitro models for drug screening

被引：1
|
作者：
Hunter, Zoe L. [1 ]
Leeson, Hannah C. [1 ]
Shaker, Mohammed R. [1 ]
Wolvetang, Ernst J. [1 ]
Vadlamudi, Lata [2 ,3 ]
机构：
[1] Univ Queensland, Australian Inst Bioengn & Nanotechnol AIBN, Brisbane, Qld 4072, Australia
[2] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld 4029, Australia
[3] Royal Brisbane & Womens Hosp, Dept Neurol, Brisbane, Qld 4029, Australia
来源：
STEM CELL RESEARCH | 2022年 / 60卷
关键词：
D O I：
10.1016/j.scr.2022.102673
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
In this paper, we describe the generation and validation of human induced pluripotent stem cell (hiPSC) lines from peripheral blood mononuclear cells (PBMCs) from 6 epilepsy patients using a non-integrative Sendai virus vector. These human cellular models will enable patient-specific drug screening to improve outcomes for individuals with this disorder.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Human Induced Pluripotent Stem Cells from Type 2 Diabetes Patients for In Vitro Drug Screening
    Teo, Adrian K. K.
    Windmueller, Rebecca
    Valdez, Ivan
    Goldfine, Allison B.
    Smith, Dave M.
    Kulkarni, Rohit N.
    DIABETES, 2013, 62 : A567 - A567
  • [2] Human In Vitro Models of Epilepsy Using Embryonic and Induced Pluripotent Stem Cells
    Javaid, Muhammad Shahid
    Tan, Tracie
    Dvir, Naomi
    Anderson, Alison
    J. O'Brien, Terence
    Kwan, Patrick
    Antonic-Baker, Ana
    CELLS, 2022, 11 (24)
  • [3] Advanced In Vitro Lung Models for Drug and Toxicity Screening: The Promising Role of Induced Pluripotent Stem Cells
    Moreira, Anabela
    Mueller, Michelle
    Costa, Pedro F.
    Kohl, Yvonne
    ADVANCED BIOLOGY, 2022, 6 (02):
  • [4] Use of Cartilage Derived From Murine Induced Pluripotent Stem Cells for Osteoarthritis Drug Screening
    Willard, Vincent P.
    Diekman, Brian O.
    Sanchez-Adams, Johannah
    Christoforou, Nicolas
    Leong, Kam W.
    Guilak, Farshid
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (11) : 3062 - 3072
  • [5] Cardiomyocytes derived from human pluripotent stem cells for drug screening
    Zeevi-Levin, Naama
    Itskovitz-Eldor, Joseph
    Binah, Ofer
    PHARMACOLOGY & THERAPEUTICS, 2012, 134 (02) : 180 - 188
  • [6] INDUCED PLURIPOTENT STEM CELLS AND THEIR USE IN HUMAN MODELS OF DISEASE AND DEVELOPMENT
    Karagiannis, Peter
    Takahashi, Kazutoshi
    Saito, Megumu
    Yoshida, Yoshinori
    Okita, Keisuke
    Watanabe, Akira
    Inoue, Haruhisa
    Yamashita, Jun K.
    Todani, Masaya
    Nakagawa, Masato
    Osawa, Mitsujiro
    Yashiro, Yoshimi
    Yamanaka, Shinya
    Osafune, Kenji
    PHYSIOLOGICAL REVIEWS, 2019, 99 (01) : 79 - 114
  • [7] Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders
    Chamberlain, Stormy J.
    Li, Xue-Jun
    Lalande, Marc
    NEUROGENETICS, 2008, 9 (04) : 227 - 235
  • [8] Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders
    Stormy J. Chamberlain
    Xue-Jun Li
    Marc Lalande
    Neurogenetics, 2008, 9 : 227 - 235
  • [9] Induced pluripotent stem cells as cardiac arrhythmic in vitro models and the impact for drug discovery
    Saric, Tomo
    Halbach, Marcel
    Khalil, Markus
    Er, Fikret
    EXPERT OPINION ON DRUG DISCOVERY, 2014, 9 (01) : 55 - 76
  • [10] In vitro Neuromuscular Junction Induced from Human Induced Pluripotent Stem Cells
    Lin, Chuang-Yu
    Yoshida, Michiko
    Li, Li-Tzu
    Saito, Megumu K.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (166): : 1 - 12
12345